Structural requirements for b1 integrin cytoplasmic domain functions in adhesion, migration and signaling have been studied mainly for ®broblasts in vitro. The relevance for b1-dependent in vivo migration of lymphoid cells has not been assessed. To study this, we transfected b1 mutants into b1-de®cient double knockout (DKO) ESb lymphoma cells, and tested the capacity of the cells to metastasize to liver and spleen. This was compared to a4b1-dependent invasion into cell monolayers in vitro and Mn
Introduction
Integrins are heterodimeric cell surface proteins involved in attachment of cells to extracellular matrix proteins or to other cells (Hynes, 1992) . In addition, integrins also transmit signals into the cell. Ligand binding and integrin clustering lead to recruitment of multiple proteins involved in signal transduction (Schlaepfer and Hunter, 1998) . This is often referred to as`outside-in signaling'. Integrin ligation and clustering also lead to reorganization of the actinbased cytoskeleton, which is required for cell spreading and migration. Small GTPases of the Rho family are involved in these post-receptor events (Keely et al., 1998) .
In blood cells, integrins often do not bind constitutively to ligands but require activation by signals from within the cell, a phenomenon termed`inside-out' signaling. For instance, migration of leukocytes into tissues depends on chemoattractants that activate integrins via G protein-coupled receptors (Baggiolini, 1998) . Also receptors such as CD2 or CD28 trigger integrins upon ligand binding (Shimizu et al., 1995; Zell et al., 1996) . Recently, several proteins that bind to integrin cytoplasmic domains were identi®ed using the yeast two-hybrid assay. These proteins are potentially involved in signaling. Examples are cytohesin-1, Rack1 and ICAP-1 (Kolanus et al., 1996; Liliental and Chang, 1998; Chang et al., 1997) .
Several amino acids and motifs within integrin b subunit cytoplasmic domains have been implicated in integrin function, such as the two NPXY sequences which are potential phosphorylation sites. Indeed, tyrosine phosphorylation of the membrane-proximal NPXY plays a role in the regulation of aVb3 integrin avidity (Blystone et al., 1997) . In b2 integrins tyrosine phosphorylation does not play a role because the b2 subunit contains NPXF instead of NPXY motifs. Furthermore, the b2 subunit contains a stretch of three threonines located between the two NPXF motifs, which was reported to become phosphorylated after phorbol ester treatment or ligation of the CD3 antigen (Valmu and Gahmberg, 1995; Valmu et al., 1999) , and mutation of the threonines to alanines prevented b2-dependent cell spreading (Peter and O'Toole, 1995) . The b1 subunit contains a VTT sequence instead of TTT. These two threonines appear to be important for adhesion of ®broblast cells (Wennerberg et al., 1998) .
These studies were mainly focused on in vitro adhesion, spreading and migration of anchoragedependent cells, that do not require integrin activation. The relevance was dicult to assess because integrin mutants were transfected into cells that expressed the wild-type (wt) integrin, or did not contain that integrin and may have lacked the appropriate interacting proteins as well. This situation changed when b1-negative cell lines, derived from dierentiated knockout embryonic stem cells, became available. This enabled elegant in vitro studies on b1 function (Wennerberg et al., 1996 (Wennerberg et al., , 1998 Sakai et al., 1998b) . However, the role of b1 in blood cells, which require integrin activation to adhere, was not addressed. Recently, this role was studied in b1-negative chemical mutants of the Jurkat T cell line, but the signi®cance for in vivo migration is not clear (Romzek et al., 1998) .
We previously generated b1 integrin-negative ESb Tlymphoma cells by homologous recombination (Stroeken et al., 1998) . ESb cells express a4b1 and a6b1, and are highly metastatic to the liver and the red pulp of the spleen, where the a4b1 ligands ®bronectin and VCAM-1 are abundantly present. In contrast, the cells do not metastasize to lungs or kidneys in which the a6b1 ligand laminin is the most abundant, suggesting that a4b1 is the relevant integrin. In contrast, the b1 integrin-negative double knockout (DKO) cells hardly metastasized to liver and spleen, resulting in extended survival of the mice. In the present study, we transduced wt b1 and b1 cytoplasmic domain mutants into the DKO cells to assess the role of speci®c residues in b1-dependent invasion in vitro and in vivo. The results show that the two threonines in the inter-NPXY domain as well as the ®ve C-terminal amino acids are essential for b1-dependent adhesion, migration and metastasis. The tyrosine residues in the NPXY motifs are dispensable for migration and metastasis but required for adhesion. The same phenomenon was observed with cells expressing a b1b2 chimeric subunit, containing phenylalanines instead of tyrosines at the homologous sites.
Results

Generation of transfectants
To identify residues in the b1 cytoplasmic domain that are important for b1-dependent invasion and metastasis of ESb lymphoma cells, we transfected mutant b1 cDNAs into b1-de®cient ESb DKO cells. We focused on residues that have been implicated in`inside-out' or outside-in' signaling. The mutants are listed in Figure  1 . Already 1 ± 2 weeks after transfection with the retroviral vector used, a zeocin-resistant cell population was obtained that expressed the b1 subunit homogeneously, so that further sorting was not necessary. All experiments were thus performed with bulk populations, not clones, excluding the possibility that dierences in behavior would be caused by clonal variation. The surface levels of the mutants were comparable (Figure 2 ). The same was true for the a4 subunit. Note that in DKO cells the a4 subunit is present on the cell surface as a monomer, and not associated with b7, as described in Stroeken et al. (1998) .
Invasion into monolayers of BMS2 cells
In the search for an in vitro model for invasion, we found that ESb cells massively invaded monolayers of murine BMS2 bone marrow stromal cells (Pietrangeli et al., 1988) , whereas DKO cells did not invade at all. Invasion of DKO cells reexpressing the wt b1 subunit was blocked by a4-blocking mAbs (PS/2 and R1-2) but not by the a6-blocking mAb GoH3 (Figure 3a and data not shown). Invasion of cells expressing mutant b1 that invaded the monolayers (see below) was similarly inhibited by the antibodies (data not shown). This shows that a4b1 is the main, if not the only, integrin involved. The eect of b1 cytoplasmic domain mutations are shown in Figure 3b . The T788,789A double mutation completely blocked invasion. The Y783F mutation had no eect at all, whereas invasion of the Y783,795F double mutant transfectants was reduced by *50%. We could not determine whether this requires mutation of both tyrosines or only Y795 because multiple attempts to express a single Y795F mutant have so far failed. We veri®ed that the sequence was correct, inserted the cDNA in dierent isolates of the vector that did work with the other mutants, and transfected the construct several times in parallel with the other mutants that did get readily expressed. The reason for this failure is not clear since the mutant has been expressed in other cell lines (Romzek et al., 1998) . Finally, deletion of the last ®ve amino acids (D793) blocked invasion completely.
Adhesion to fibronectin
It is dicult to induce adhesion of ESb cells to the a4b1 ligand ®bronectin, because reagents such as phorbol esters, that activate integrins by`inside-out' signaling in other cell types, have no eect. So far, we
have not yet identi®ed a growth factor, cytokine, chemokine or other factor that can induce this adhesion. The cells do adhere, however, in the presence of Mn
2+
. The primary eect of Mn 2+ is supposed to be the induction of an active conformation of the extracellular domain, but its eect on adhesion of cells also requires integrin-induced`outside-in' signals such as those involved in cell spreading (Driessens et al., 1997; Retta et al., 1998; Mastrangelo et al., 1999) . Mn
-induced adhesion of the b1 transfectants to ®bronectin was assessed in the presence of a b3-blocking mAb since the cells express aVb3 which also contributes to this adhesion (Stroeken et al., 1998) . Results are shown in Figure 4 . The Y783F mutant supported adhesion to the same extent as wt b1, in line with the result of the invasion assay. The adhesion of cells expressing the T788,789A or the D793 mutant was very strongly reduced, by more than 70%, again in agreement with the invasion data. However, cells expressing the double tyrosine mutant Y783,795F also adhered very poorly, whereas they did invade quite well, although less extensively (*50%) than wt b1 cells (compare Figures 3 and 4) . Clearly, the requirements for stable adhesion in this type of assay are more stringent than for b1-dependent invasion.
In transfected b1-de®cient embryonal cell lines, mutation of these threonines led to reduced binding of the 9EG7 antibody, which detects an active conformation of the b1 extracellular domain (Wennerberg et al., 1998) . However, 9EG7 did not bind to ESb cells and the 9EG7 epitope did not appear upon treatment with Mn 2+ (data not shown).
Metastatic capacity
To assess the eect of the mutations on metastasis formation, 5610 4 cells were injected into a tail vein of syngeneic DBA/2 mice. Previously, we reported that such animals become moribund after *10 days, due to extensive metastatis formation in liver and spleen. In contrast, of mice injected with DKO cells *50% die, but only after an extended period of 20 ± 60 days (see Figure 5a ). In these mice no or limited liver and spleen metastasis was seen but skeletal muscles were heavily invaded, causing hind leg paralysis (Stroeken et al., 1998) .
Similarly as before, mice injected with DKO cells that re-express wt b1 died after *10 days, with massively invaded livers and spleens ( with the lack of eect on invasion and adhesion. Similarly, the D793 mutant which did not support adhesion or invasion, did not confer metastatic capacity. In fact, the phenotype appeared less severe than that of DKO cells: only 15% of the mice became moribund and these animals had no tumors in liver, spleen or muscle (Figure 5b ). Instead, they had developed ascites and a tumor in the abdomen. For the double threonine mutant the results were also clear. This mutation did not restore metastatic capacity: the survival curve was essentially identical to that of mice injected with DKO cells, and invasion mainly occurred in skeletal muscle (compare Figure 5a and c). Only 20% of the mice had liver and spleen metastasis, restricted to one focus or a few small foci. This in vivo behavior correlated with the in vitro adhesion and invasion data.
Initially, it appeared that the Y783,795F double mutation led to reduced metastasis formation and increased survival, as compared to wt b1. Strikingly, however, mice that were sacri®ced early because they developed hind leg paralysis did have liver and spleen metastases, that were no longer found in mice killed after longer time periods. This suggested that liver and spleen metastases developed but were rejected later. We described a similar phenomenon previously for b1-transfected DKO cells (at a lower cell dose) compared to the parental ESb cells (Stroeken et al., 1998) . We proposed that the clone from which the DKO cells were derived proliferated somewhat slower in the tissues, causing a shift in balance between proliferation and a host defense reaction against these cells in syngeneic mice, as described by Schirrmacher et al. (1979) . To investigate this, all mice were sacri®ced after 9 days in a second experiment. Indeed, all animals injected with Y783,795F cells (10/10) had foci in liver and spleen and there was no dierence between the wt and the mutant b1 transfectants (see Table 1 ). We conclude that the Y783,795F double mutation does not aect initial metastasis formation but appears to reduce long-term survival in the liver and spleen.
To study whether the same phenomenon also occurred with the D793 and T788,789A cells, we injected ten animals per cell line and examined metastasis formation after 9 days. None of these animals had developed foci in the liver. Also, no spleen metastases were seen in mice injected with the D793 transfectant. However, the T788,789A transfectant formed spleen metastasis in 8/10 mice, in half of the animals quite extensive (see Table 1 ). We conclude that the D793 transfectant does not metastasize to liver and spleen and that the threonine mutant transfectant can not form liver metastases. However, the threonine mutant does seem capable of forming metastases in the spleen. Nevertheless, since the survival of mice is similar to those injected with DKO cells (see Figure 5) , and none of these mice contained foci in the spleen upon autopsy, these spleen metastases appear to be rejected with time.
A b1b2 chimera restores invasion and metastasis but not adhesion
The results obtained with Y783F and Y783,795F mutant cells suggested that tyrosine 795 was required for stable adhesion but less so for invasion and metastasis formation. This notion was con®rmed by the behavior of cells expressing a b1b2 chimeric subunit with the b2 cytoplasmic domain which also contains phenylalanines instead of tyrosines in the NPXY/F motifs (see Figure 1) . The b1b2 surface levels were comparable to the b1 levels on the wt b1 transfectants and the b1b2 transfectants invaded BMS2 monolayers to a similar extent as the wt b1-expressing cells (Figure 6a,b) . Also metastasis formation and survival were comparable. More than 80% of the mice became moribund after the same time period as the control b1 transfectants (Figure 6c) , with massively invaded livers and spleens and hind leg paralysis. However, Mn 2+ -induced adhesion of these cells was very low (Figure 6d ) and similar to the cells expressing the Y783,795F mutant. We conclude that the tyrosines in the b1 cytoplasmic domain, and possibly only tyrosine Y795 in the C-terminal NPXY motif, are required for Mn 2+ -induced a4b1-mediated adhesion to ®bronectin but not for a4b1-dependent invasion into cell monolayers or metastasis formation.
Interaction of ICAP-1 with integrin b subunits ICAP-1, which speci®cally interacts with the b1 integrin subunit, has been implicated in cell adhesion, spreading and migration (Chang et al., 1997; Zhang and Hemler, 1999) . Several of the 13 b1 C-terminal amino acids are Table 1 Metastasis formation in liver and spleen after 9 days Liver Spleen b1 10/10 10/10 Y783,795F 10/10 10/10 T788,789A 0/10 8/10 D793 0/10 0/10 DBA/2 mice were injected with 5610 4 cells into a tail vein, sacri®ced after 9 days, and metastasis formation was determined macroscopically. Indicated is the number of animals with metastasis in liver or spleen required for this interaction. However, the role of T788 and T789 was not assessed. Using the yeast two-hybrid assay, we con®rmed that ICAP-1 binds to b1, but not b2, and found that the double threonine mutant does not bind to ICAP-1 (data not shown).
Discussion
To de®ne mechanisms involved in b1-dependent metastasis of ESb lymphoma cells, we studied the eects of b1 cytoplasmic domain mutations on metastasis and on b1-dependent invasion and adhesion. Invasion of ESb cells was assessed using monolayers of a bone marrow stromal cell line. This invasion was rapid and massive and completely dependent on a4b1. ESb cells express two b1 integrins, a4b1 and a6b1, and metastasize to the liver and spleen which contain the a4b1 ligands ®bronectin and VCAM-1 but very little laminin, the ligand of a6b1. Thus, a4b1 is probably the relevant integrin (Stroeken et al., 1998) , and this assay is therefore an appropriate model for b1-mediated invasion during metastasis formation. Adhesion was induced with Mn
2+
, because ESb cells do not respond to the protein kinase C activator PMA, which is generally used to induce integrin-mediated adhesion, and because we have not yet identi®ed chemokines, cytokines or other factors that might be the physiological activators of b1 integrin on ESb cells in vivo. The primary eect of Mn 2+ is a conformational change of the extracellular domain which is probably not aected by the mutations.
Adhesions of cells induced by Mn
2+ also depends on post-receptor (`outside-in') signaling events that require intact cytoplasmic domains (Driessens et al., 1997; Retta et al., 1998; Mastrangelo et al., 1999) , and the eect of the mutations seen are therefore quite probably due to their impact on post-receptor events.
The most straightforward conclusions can be drawn about two of the mutants, D793 and Y783F. Deletion of the ®ve C-terminal residues (D793) abolished adhesion, invasion and metastasis. The results show that these residues are extremely important, either for cytoskeletal connections or interactions with signaling molecules, or both. Previously, they were shown to be required for tyrosine phosphorylation induced by a4b1 cross-linking (Finkelstein et al., 1997; Hunter and Shimizu, 1997) , e.g. of Cas proteins that have been implicated in cell migration (Klemke et al., 1998) . However, we have not been able to induce such phosphorylation in ESb cells (P Stroeken, unpublished results). The C-terminal part is also essential for binding of ICAP-1, a protein that interacts speci®cally with b1, is phosphorylated upon adhesion to ®bro-nectin, and promotes migration when overexpressed (Chang et al., 1997; Zhang and Hemler, 1999) . ICAP-1 is expressed in ESb cells, as assessed by RT ± PCR (not shown). It is thus conceivable that the eect of the mutation is due to the inability to bind ICAP-1.
In contrast, the Y783F mutation had no eect at all on adhesion, invasion and metastasis. The homologous mutation in b3 prevents the phosphorylation of this residue, which is required for b3 function in K562 cells in which integrins require activation similarly as in most blood cells, whereas this tyrosine is not essential in melanoma cells in which aVb3 is constitutively active (Filardo et al., 1995; Blystone et al., 1997) . We thus expected that Y783 phosphorylation was required for activation of a4b1 in ESb cells in vivo. Our results show, however, that the tyrosine is dispensable. This indicates that a4b1 is activated by a dierent mechanism or, alternatively, that activation is not required for the role of a4b1 in invasion and metastasis formation.
The strongly reduced adhesion and invasion of the double threonine mutant cells is also in line with the lack of metastasis to the liver. However, in this case some spleen metastasis was observed in mice sacri®ced after 9 days. The dierence between liver and spleen may re¯ect distinct requirements in the two organs. As discussed in Stroeken et al. (1998) , the cells invade through the endothelium into the liver tissue whereas in the spleen the cells are probably passively transported through openended arterioles into the ®bronectin-rich meshwork of the red pulp (Weiss, 1963) . The threonine mutant cells may have some residual capacity to attach to this meshwork whereas they can not invade the liver. Strikingly, however, this metastasis formation in the spleen did not shorten the survival time of the mice. In fact, no spleen foci were observed at later time points, indicating that these had disappeared. A similar phenomenon was observed previously for DKO cells transfected with wt b1 (Stroeken et al., 1998) . We proposed that the clone from which the DKO cells were derived had a slightly reduced survival or proliferation capacity in vivo, allowing the mice to reject the cells by a host defense reaction. In line with this notion, the problem was overcome by increasing the injected dose from 10 4 to 5610 4 cells. In the present study the eect was also observed for the Y783,795F mutant cells, that initially formed metastases in liver and spleen, to the same extent as wt b1 transfectants. Yet, survival of the mice was the same as observed with untransfected DKO cells. Apparently, both mutations lead to a reduced survival and/or proliferation capacity in vivo, allowing the mice to reject the cells.
A three residue sequence containing two or three threonines is located between the two NPXY/F motifs in most b subunit cytoplasmic domains. These residues were shown to be required for b2 function in adhesion assays (Hibbs et al., 1991; Peter and O'Toole, 1995) . Replacement by alanines impaired b2-mediated cell adhesion without an eect on ligand anity, and was ascribed to eects on post-receptor events required for cell spreading. In contrast, the mutations did not aect b2-dependent transendothelial migration (Weber et al., 1997) . The role of the threonines in b1 was studied in b1-de®cient embryonal cells, and shown to be required for adhesion. Mutation of these threonines led to reduced levels of the 9EG7 antibody epitope. This antibody detects an active conformation of the b1 extracellular domain (Wennerberg et al., 1998) . We found that, in contrast to the reported eects on b2 function, replacement of the b1 threonines impaired not only adhesion but also invasion into cell monolayers in vitro as well as invasion in vivo. This con®rms the important role of these threonines in b1 function. However, the 9EG7 epitope was not detected on ESb cells and did not appear upon treatment with Mn 2+ , indicating that the threonine mutations had no eect on the extracellular conformation detected by this antibody.
The threonines in b2 were reported to be phosphorylated upon PMA treatment, although this could b1 integrin in lymphoma invasion PJM Stroeken et al only be shown when a phosphatase inhibitor was added (Valmu and Gahmberg, 1995) . Such phosphorylation has, to the best of our knowledge, not been reported for the b1 threonines, but phosphorylation may be transient and not easy to detect. An alternative possibility is suggested by our ®nding that the double threonine mutant does not bind to ICAP-1, supporting the notion that ICAP-1 may be involved. The eects of the tyrosine double mutation (Y783,795F) were surprising because they are the opposite of results reported for b1-de®cient embryonic ®broblasts (Sakai et al., 1998a,b) , in which the mutant supported adhesion whereas chemotaxis through ®bronectin-coated ®lters was impaired. In contrast, we found that migration of the lymphoid ESb-DKO transfectants, as detected in the invasion assay, was only partially inhibited. Furthermore, invasion of the cells into the liver in vivo, as assessed after 9 days, was comparable to that of wt b1 transfectants. In contrast, adhesion to ®bronectin was strongly reduced. The role of the tyrosines is not clear. It is assumed that their phosphorylation is required (Sakai et al., 1998b) , but this has not been demonstrated. Phosphorylation of the homologous tyrosines in b3 appears to be required for linkage to the cytoskeleton, possibly by direct binding to myosin (Jenkins et al., 1998) . It remains to be demonstrated whether this is also true for b1.
Since the Y783F had no eect on b1 function, it seems likely that the Y795F mutation is responsible for the reduced adhesion. We could not express the single Y795F mutant, so this remains to be established. However, assuming that only the Y795F mutation is responsible, this result diers from that of Romzek et al. (1998) who found that exchange of Y795 by a phenylalanine did not aect CD3-or PMA-induced b1-mediated adhesion of Jurkat T cells, although a mutation to alanine did reduce adhesion. This dierence may be due to distinct mechanisms triggered by PMA and CD3, as compared to Mn 2+ . In this context it is remarkable that an aLb2 integrin containing a b2b7 chimeric subunit, which contains a phenylalanine in the second NPXY motif and a tyrosine in the ®rst NPXY motif was unable to mediate PMA-induced adhesion. In contrast, aLb2 containing a b2b1 chimeric subunit was as responsive as endogenous b1 integrins (Lub et al., 1997) . This also suggests that the C-terminal tyrosine is the most important.
Strikingly, the distinct eects on adhesion and invasion of the Y783,795F mutation were con®rmed using DKO cells transfected with the b1b2 chimera. The b2 cytoplasmic domain contains phenylalanines instead of tyrosines in the NPXY/F motifs, similarly as in the Y783,795F double mutant. In agreement with this, the cells expressing the chimera adhered very poorly to ®bronectin after stimulation with Mn 2+ , but did invade the BMS2 cell monolayer, to the same extent as wt b1-transfected cells. The b1b2-transfected cells metastasized almost as eciently as the wt b1-transfected cells, indicating that the b1-dependent invasion, as determined in the monolayer assay, is the relevant function in vivo. This invasion is probably not dependent on ICAP-1, which does not bind to b2 (Chang et al., 1997) . However, the signaling pathways and cytoskeleton interactions are likely to be speci®c for b2 and may involve distinct proteins. We conclude that part of the functions of the b1 cytoplasmic domain that are required for stable adhesion, are not essential for b1-dependent invasion and not for metastasis formation.
Materials and methods
Generation of mutant b1 integrin subunits
Mutant b1 constructs were generated by PCR using murine b1 cDNA as template. The sense primer contained the RcaI site in the region encoding the membrane-proximal part of the cytoplasmic domain. For the b1b2 chimeric subunit we used an antisense primer in which the internal b2 RcaI site was abolished. All antisense primers contained a NotI site next to the stop codon. The RcaI ± NotI fragments and a BamHI ± RcaI fragment encoding the extracellular and transmembrane domain of b1 were ligated in the BamHI ± NotI digested LZRS-IRES-Zeo vector (Kinsella and Nolan, 1996; Michiels et al., manuscript in preparation) . The nucleotide sequence of the cytoplasmic domain of the constructs was con®rmed by sequence analysis.
Cell lines and culture conditions
We used one of the three b1-de®cient ESb cells that were previously generated, ESb-DKO 18/22 cells (Stroeken et al., 1998) . DKO and transduced cells were cultured in enriched RPMI 1640 medium (Hybridoma medium, Roossien et al., 1989) . Phoenix cells (kindly provided by Dr GP Nolan) were cultured in Dulbecco's Modi®ed Eagle's Medium (DMEM), supplemented with 10% FCS and 1% L-glutamine. BMS2 cells were cultured in DMEM supplemented with 5% FCS and 0.0004% 2-mercaptoethanol.
Transfections of Phoenix cells and transduction of DKO cells
Constructs were transfected by calcium phosphate precipitation into the ecotropic viral packaging cell line Phoenix (Grignani et al., 1998) . Twenty-four hours before transfection, 1.6610 6 Phoenix cells were seeded in a culture dish (Falcon, Becton Dickinson, NJ, USA). Immediately before transfection the medium was replaced by medium supplemented with 25 mM chloroquin. Ten mg DNA in 450 ml H 2 O was mixed with 50 ml 2.5 M CaCl 2 and subsequently with 500 ml 26HBS (50 mM HEPES pH 7.05, 10 mM KCl, 280 mM NaCl, 1.5 mM Na 2 HPO 4 , 12 mM D-glucose) and added to the Phoenix cells. After 8 and 24 h incubation the cells were washed. The supernatant was collected 72 h after transfection and centrifuged at 1200 r.p.m. for 5 min, and 1 ml was mixed with 10 ml DOTAP (Boehringer Mannheim) and added to 10 5 DKO cells. After 8 h, the medium was refreshed and after 72 h, 200 mg/ml zeocin was added.
Antibodies and FACScan analysis
The hamster anti-rat b1 mAb Ha2/5, the rat anti-mouse a4 mAb 9C10 and the rat anti-mouse b3 mAb 2C9.G2 were purchased from Pharmingen (San Diego, CA, USA). Hybridomas producing rat anti-mouse a4 mAbs PS/2 and R1-2 were obtained from the ATCC. Rat anti-human a6 mAb GoH3 was kindly provided by Dr A Sonnenberg. Goat anti-rat and anti-mouse phycoerythrin-labeled F(ab') 2 fragments (Jackson ImmunoResearch, West Grove, PA, USA) were used as secondary antibodies.
In vitro adhesion and invasion assays
In vitro adhesion assays were performed as described before (Stroeken et al., 1998) . For in vitro invasion assays, BMS2 bone marrow stroma cells (Pietrangeli et al., 1988) were seeded in 24-well plates (Falcon) and grown to 80% con¯uence. ESb cells were washed twice with RPMI 1640 medium, and resuspended in RPMI 1640 medium (5610 5 cells/ml). BMS2 cells were washed twice with RPMI 1640 medium and 2.5610 5 ESb cells were added per well. After 4 h incubation at 378C and 5% CO 2 , plates were washed with PBS, and cells ®xed with 2% paraformaldehyde in PBS supplemented with 1 mM Ca 2+ and 1 mM Mg
2+
. Invaded cells were counted using phase contrast microscopy. The a4 mAbs PS/2 and R1-2, and the a6 mAb GoH3 were used to block a4 or a6 integrins, respectively. In these experiments, ESb cells were incubated with antibody for 30 min at 378C before addition to the BMS2 cells.
Experimental metastasis assays
To compare metastatic capacity of the b1-transduced cells, 5610 4 cells in 100 ml PBS supplemented with 1 mM Mg 2+ and 1 mM Ca 2+ were injected into a lateral tail vein of syngeneic DBA/2 mice. Animals were autopsied when moribund or after a ®xed time period. Metastasis formation was determined macroscopically.
Yeast two-hybrid interactions
The yeast two-hybrid interaction assay was performed essentially as described before (Schaapveld et al., 1998) . The b subunit cDNAs were cloned in pAS2-1 and full length murine ICAP-1 (Faisst and Gruss, 1998) , ampli®ed from ESb cDNA, in pACT2 (Clontech, Palo Alto, CA, USA). Sequence analysis showed that the coding sequences in the yeast plasmids were correct. PJ69-4A yeast cells were cotransformed with a pACT2 and a pAS2-1 plasmid, and aliquots spread on plates containing SC-LT medium, medium lacking only Leu and Trp, and SC-LTHA medium, lacking in addition the interaction markers His and Ade. The number of colonies on the SC-LT and SC-LTHA plate were compared.
